Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

60°
- Benton, AR (72018)
  Today
  
  Occasional light rain tapering to a few showers late. High 64F. Winds W at 10 to 20 mph. Chance of rain 80%..
  
  Tonight
  
  Clear skies. Low 32F. Winds NW at 10 to 15 mph.
  
  Updated: December 18, 2025 @ 10:19 am
- Full Forecast

- Site search

Home
News
- Local News
Sports
Obituaries
Multimedia
- Photo Galleries
- Videos
e-Edition
Classifieds
Archives
Readers Choice 2025

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

4.667 -0.013 (-0.29%)

Streaming Delayed Price Updated: 11:35 AM EST, Dec 18, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

21 22 Next >

History of Recursion Pharmaceuticals, Inc.: AI‑Driven Drug Discovery Beginnings (NASDAQ:RXRX)

July 21, 2025

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) emerged in the 2010s as one of the pioneers in leveraging artificial intelligence (AI) and advanced data analytics to transform drug discovery and...

Via MarketMinute

Topics Artificial Intelligence

Is Recursion Pharmaceuticals Gaining or Losing Market Support? ↗

July 21, 2025

Via Benzinga

Why Is Recursion Pharma Stock Surging On Monday? ↗

July 21, 2025

Recursion's AI-designed cancer drugs REC-3565 and REC-617 show early clinical promise, with one patient responding unexpectedly well to treatment.

Via Benzinga

Galaxy Digital, Blaize Holdings, Verizon And Other Big Stocks Moving Higher On Monday ↗

July 21, 2025

Via Benzinga

Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia

July 08, 2025

From Recursion Pharmaceuticals

Via GlobeNewswire

Jensen Huang's Nvidia Owns 6 Stocks. Here's the Best of the Bunch. ↗

July 12, 2025

Via The Motley Fool

Topics Artificial Intelligence Initial Public Offering Intellectual Property

10 Under-the-Radar Tech Stocks With Incredible Growth Potential ↗

July 09, 2025

Just because it's not a household name doesn't mean it's not a magnificent investment.

Via The Motley Fool

Topics Artificial Intelligence

Here's Why Shares in Recursion Pharmaceuticals Surged Today ↗

July 08, 2025

Via The Motley Fool

Microchip Technology, Tesla, Humacyte And Other Big Stocks Moving Higher On Tuesday ↗

July 08, 2025

Via Benzinga

Why Is Microcap Rallybio Stock Trading Higher On Tuesday? ↗

July 08, 2025

Rallybio sells its stake in preclinical HPP drug REV102 to Recursion in a deal worth up to $25 million, including equity and milestone payments.

Via Benzinga

The Hottest 10 Artificial Intelligence (AI) Stocks on the Market ↗

July 08, 2025

This group of companies reflects most of the industry's past, present, and future.

Via The Motley Fool

Topics Artificial Intelligence

Doctors Are Being Outpaced by AI-Powered Algorithms — Here’s What It Means for Investors

July 07, 2025

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:MSFT),(NASDAQ:ASTH),(NASDAQ:RXRX),(NASDAQ:MDAI) EQNX::TICKER_END

Via FinancialNewsMedia

Topics Artificial Intelligence Fraud

Alphabet-Backed Drug Discovery Firm Nears Human Trials Of AI-Developed Remedies, Says President: 'The Next Big Milestone Is...' ↗

July 07, 2025

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are also racing to use AI in drug discovery.

Via Benzinga

Topics Artificial Intelligence

What Analysts Are Saying About Recursion Pharmaceuticals Stock ↗

July 03, 2025

Via Benzinga

Is the Market Bullish or Bearish on Recursion Pharmaceuticals? ↗

June 26, 2025

Via Benzinga

Capital Flows Shift From Research Labs to Pharmacy Counters-A Watershed Moment for AI Health

June 17, 2025

Issued on behalf of Avant Technologies Inc. Vancouver, BC – June 17, 2025 – USA News Commentary – Momentum continues to build behind AI in healthcare, as capital finds its way to technologies capable...

Via FinancialNewsMedia

Topics Artificial Intelligence

Expert Outlook: Recursion Pharmaceuticals Through The Eyes Of 4 Analysts ↗

June 16, 2025

Via Benzinga

Is This Beaten-Down Cathie Wood Artificial Intelligence (AI) Stock a Buy? ↗

June 16, 2025

Via The Motley Fool

Topics Animal Testing Artificial Intelligence Intellectual Property

Why Recursion Pharmaceuticals Was Bouncing Higher on Tuesday ↗

June 10, 2025

Via The Motley Fool

Recursion Pharmaceuticals Stock Is Up 10% Today: What's Happening? ↗

June 10, 2025

Recursion Pharmaceuticals Inc (NASDAQ:RXRX) shares are trading higher and trending. The company on Tuesday announced a reduction in personnel and infrastructure aimed at extending its cash runway.

Via Benzinga

Insmed, Tesla, Casey's General Stores And Other Big Stocks Moving Higher On Tuesday ↗

June 10, 2025

Via Benzinga

Recursion Pharmaceuticals Stock Surges After Company Lays Off 20% Workforce: Retail Predicts ‘Blue Skies’ Ahead ↗

June 10, 2025

The company now expects its projected cash runway to extend into the fourth quarter of 2027.

Via Stocktwits

Topics Artificial Intelligence Workforce

Applied Digital And Riot Platforms Are Among Top 10 Mid-Cap Gainers Last Week (Jun 2-Jun 6): Are The Others In Your Portfolio? ↗

June 08, 2025

Via Benzinga

Recursion Pharmaceuticals Stock Surges On Breakthrough AI Model Launch With MIT ↗

June 06, 2025

Shares of Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) are trading higher after the company, in collaboration with MIT, announced the release of Boltz-2, a new open-source AI model designed to predict...

Via Benzinga

Topics Artificial Intelligence

MIT and Recursion Release Boltz-2: Next Generation AI Model to Predict Binding Affinity at Unprecedented Speed, Scale, and Accuracy

June 06, 2025

From Recursion Pharmaceuticals

Via GlobeNewswire

Recursion to Participate in Upcoming Investor Conferences

May 30, 2025

From Recursion Pharmaceuticals

Via GlobeNewswire

3 Monster Stocks to Hold for the Next 10 Years ↗

May 26, 2025

A handful of industries are on the verge of explosive growth. These three companies are poised to gain the most.

Via The Motley Fool

Topics Energy

8 Health Care Stocks With Whale Alerts In Today's Session ↗

May 23, 2025

Via Benzinga

These Are the Only 6 Stock Stocks in NVIDIA's 13F Portfolio

May 22, 2025

While institutional money managers have released their Q1 holdings, so has the heart and soul of the AI revolution, NVIDIA. See which six stocks NVIDIA owns.

Via MarketBeat

Topics Artificial Intelligence Earnings

Should You Buy This Beaten-Down Artificial Intelligence (AI) Stock on the Dip? ↗

May 12, 2025

Via The Motley Fool

Topics Animal Testing Artificial Intelligence

< Previous 1 2 3 4 5 6 7 8 9

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Announcements
e-Edition
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

bentoncourier.com
321 North Market Street
Benton, AR 72018
Phone: 501-315-8228
Email: bcadmin@bentoncourier.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Benton, AR (72018)

Today

Tonight

Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock

Sections

Services

Follow Us